Shukra Pharmaceuticals Ltd. - Research Center
524632 SHUKRAPHAR Group (XT) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
10.88 |
18.89 |
24.64 |
20.16 |
46.25 |
Operating profit |
4.43 |
9.54 |
5.09 |
0.34 |
3.65 |
Interest |
0.07 |
0.07 |
0.06 |
0.08 |
0.07 |
Gross profit |
5.74 |
10.04 |
5.27 |
0.89 |
4.47 |
EPS (Rs) |
3.64 |
8.61 |
4.33 |
0.38 |
3.63 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
1.38 |
0.56 |
0.24 |
0.63 |
0.89 |
Stock adjustment |
-1.08 |
- |
1.94 |
-0.16 |
2.10 |
Raw material |
2.71 |
3.85 |
4.80 |
2.03 |
3.13 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
1.58 |
1.35 |
1.37 |
1.34 |
1.21 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
3.25 |
4.15 |
11.44 |
16.61 |
36.15 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.52 |
0.51 |
0.56 |
0.46 |
0.51 |
Taxation |
1.24 |
0.11 |
-0.01 |
0.01 |
-0.01 |
Net profit / loss |
3.99 |
9.42 |
4.71 |
0.42 |
3.98 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
10.95 |
10.95 |
10.86 |
10.96 |
10.96 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
40.74 |
50.53 |
20.65 |
1.67 |
7.90 |
GPM (%) |
46.82 |
51.62 |
21.16 |
4.26 |
9.48 |
NPM (%) |
32.51 |
48.43 |
18.93 |
2.02 |
8.44 |